The research group led by Dr. rer. med. Andrew Tony-Odigie, an early career scientist at the German Center for Lung Research (DZL-site TLRC Heidelberg) and researcher in the field of medical microbiology and hygiene at the University Hospital Heidelberg, has received a grant of 148,330 euros from the German Cystic Fibrosis Foundation (Mukoviszidose e.V). Dr. Tony-Odigie and his team are investigating the role of commensal bacteria, their metabolic products, and their impact on CFTR modulators in lung infections in cystic fibrosis patients.

For more information about the project, please click here (in German).